Pan-cancer Integrative Molecular Portrait Towards a New Paradigm in Precision Medicine / edited by Christophe Le Tourneau, Maud Kamal
Contributor(s): Le Tourneau, Christophe, editor literario
| Kamal, Maud, editor literario
Material type: 
E-bookPublisher: Cham, Switzerland : Springer, 2015Edition: 1st ed.Description: 1 recurso en línea (X, 144 p.) 100 il., 50 il. col..ISBN: 9783319221892.Subject: Ensayos clínicosDDC classification: 616.994 Online resources: Acceso a este recurso digital (usuarios Universidad Europea de Madrid)
Summary: This original book provides readers with an overview of the latest developments in personalized medicine clinical trials in oncology. The topics covered range from the rationale behind this new generation of clinical trials and the latest statistical models for high-throughput molecular techniques, bioinformatics, high-throughput screening molecular techniques and the challenges entailed by implementing them in daily practice. It also covers the key role of pathology in the validation of molecular results and the complex assessment of predictive biomarkers. The different topics covered are supplemented by unique concrete examples based on the SHIVA trial. The authors are all members of the French Curie Institute, one of the worldâ€{u3826}oremost cancer research institutions.
| Item type | Current library | Collection | Call number | Copy number | Status | Date due | Barcode | Item holds | |
|---|---|---|---|---|---|---|---|---|---|
LIBRO-E NO PRÉSTAMO
|
Madrid Digital Acceso Electrónico (UEM) | Ciencias de la Salud | R853.C55 P363 2015 EB (Browse shelf(Opens below)) | .i11578907 | Acceso electrónico | eBOOK .i11578907 |
This original book provides readers with an overview of the latest developments in personalized medicine clinical trials in oncology. The topics covered range from the rationale behind this new generation of clinical trials and the latest statistical models for high-throughput molecular techniques, bioinformatics, high-throughput screening molecular techniques and the challenges entailed by implementing them in daily practice. It also covers the key role of pathology in the validation of molecular results and the complex assessment of predictive biomarkers. The different topics covered are supplemented by unique concrete examples based on the SHIVA trial. The authors are all members of the French Curie Institute, one of the worldâ€{u3826}oremost cancer research institutions.
There are no comments on this title.